Related Experiment Video
Updated: Jul 28, 2026
10:32
Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing
Published on: January 11, 2013
Acute hypoglycemia in humans causes attentional dysfunction while nonverbal intelligence is preserved.
V McAulay1, I J Deary, S C Ferguson
1Department of Diabetes, Royal Infirmary, Edinburgh, Scotland, UK.
Diabetes Care
|September 28, 2001
Summary
Acute insulin-induced hypoglycemia impairs attention and information processing speed in healthy adults. However, sustained attention and fluid intelligence remain unaffected, suggesting specific cognitive functions are vulnerable to low blood glucose.
Area of Science:
- Neuroscience
- Endocrinology
- Cognitive Psychology
Background:
- Hypoglycemia, or low blood glucose, is known to cause cognitive dysfunction.
- The extent to which neuropsychological tests reflect real-world cognitive abilities during hypoglycemia is unclear.
Purpose of the Study:
- To investigate the effects of acute insulin-induced hypoglycemia on attention and intelligence in non-diabetic individuals.
- To determine if cognitive impairments during hypoglycemia correlate with everyday functional abilities.
Main Methods:
- A hyperinsulinemic glucose clamp technique was used to induce controlled euglycemia and hypoglycemia in 20 healthy volunteers.
- Cognitive function was assessed using the Test of Everyday Attention and Raven's Progressive Matrices under both conditions.
Main Results:
- Hypoglycemia significantly impaired tests of visual and auditory selective attention.
- Attentional flexibility decreased, and information processing speed was delayed during hypoglycemia.
- Sustained attention and intelligence scores remained preserved.
Conclusions:
- Moderate hypoglycemia leads to significant deficits in attentional abilities.
- Fluid intelligence is preserved, but complex attention tasks relevant to daily life may be impaired.
- These findings highlight the specific cognitive vulnerabilities associated with hypoglycemia.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...